How have targeted therapies improved cancer outcomes?
Targeted therapies are designed to specifically attack cancer cells without affecting normal cells. These treatments focus on specific molecules and cellular pathways critical to cancer growth and survival. For instance, HER2-positive breast cancer patients have benefited from drugs like trastuzumab, which targets the HER2 protein. Similarly, BRAF inhibitors have shown success in treating melanoma by targeting specific mutations in the BRAF gene.
